Prospective Comparison of 64Copper [64Cu]SAR-bisPSMA vs 68Gallium[68Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial)
Sobia Khan, Nathan Papa, Andrew Kneebone, Thomas Eade, Narjess Ayati, Andrew Nguyen, Keith Wong, Jeff Chen, Bao Ho, Jordan Idiare, George Sidhom, Matthew J Roberts, James Thompson, Shikha Sharma, Shraddha Weir, Katrina Devitt, Raji Kooner, Hester Lieng, Kris Rasiah, Joanna Olphert, Jeremy de Leon, George Hruby, Phillip D. Stricker, Louise Emmett
原始摘要（英文原文）· Original abstract
BACKGROUND AND OBJECTIVE: Ga-PSMA) in BCR post radical prostatectomy (RP) (NCT06907641). METHODS: Cu-bisPSMA). The primary endpoint was mean per-participant lesional difference. Paired t tests and mixed-effects Poisson regression assessed lesion number differences between scans. KEY FINDINGS AND LIMITATIONS: Ga-PSMA, respectively. CONCLUSION AND CLINICAL IMPLICATIONS: Ga PSMA-PET/CT with substantial management impact and a high RS true positive rate in men with BCR post RP.
Prospective Comparison of 64Copper [64Cu]SAR-bisPSMA vs 68Gallium[68Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial) — 科研速览 Science Skim